Entrada Therapeutics (TRDA) Tax Rate (2023 - 2026)

Entrada Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 0.1% for Q1 2026.

• In Q1 2026, Tax Rate changed N/A year-over-year to 0.1%; the TTM figure through Mar 2026 stood at 0.6% (up 331.0% YoY), while the FY2025 annual figure was 0.63%, down 192.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.1%, up from 0.26% in the prior quarter.
• The five-year high for Tax Rate was 253.04% in Q4 2024, with the low at 114.62% in Q2 2023.
• The 4-year median for Tax Rate is 0.18% (2026), against an average of 12.76%.
• The sharpest annual moves came in 2024 and 2025: Tax Rate surged 12093 bps in 2024, then sank 25330 bps in 2025.
• Entrada Therapeutics' Tax Rate stood at 203.33% in 2023, then increased by 24 bps to 253.04% in 2024, then tumbled by 100 bps to 0.26% in 2025, then surged by 63 bps to 0.1% in 2026.
• Business Quant data shows TRDA's Tax Rate at 0.1% in Q1 2026, 0.26% in Q4 2025, and 1.5% in Q3 2025.